Search

everythinglearnresearchcommunity

for

Search:↓

The dutasteride nanoemulsion could improve hair loss treatment by enhancing drug penetration and retention in hair follicles.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

RU 58841 may treat acne, hair loss, and excessive hair growth.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Tiny lipid particles carrying 17-α-estradiol gather in hair follicles, which may help target alopecia treatment.

Finasteride helps female-pattern hair loss.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Nandrolone might increase muscle mass with fewer side effects than testosterone but could cause erectile dysfunction and needs more research.

Finasteride in lipid carriers improved hair growth in rats.

2-Hydroxy-1,4-naphthoquinone is a strong 5α-reductase inhibitor.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Researchers created a skin patch that delivers two drugs for treating enlarged prostate, which may improve patient use and dosage control.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

3α-androstanediol helps reduce age-related cognitive and mood declines in male rats, unlike testosterone.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

A new method was developed to analyze certain hormones and drugs in human blood efficiently.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.